Can a common heart drug prevent deadly bleeding in liver disease?
NCT ID NCT06861075
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 25 times
Summary
This study tests whether carvedilol, a drug usually used for heart conditions, can lower high blood pressure in the liver's main vein to prevent dangerous bleeding in people with cirrhosis. About 30 adults with cirrhosis and signs of high liver pressure will take carvedilol for one month. Researchers will use a special ultrasound to measure pressure changes and check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu Estaing Medecine Digestive Et Hepatobiliaire
RECRUITINGClermont-Ferrand, 63003, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lise Laclautre
NOT_YET_RECRUITINGClermont-Ferrand, 63000, France
Contact
Conditions
Explore the condition pages connected to this study.